For instance, in the HER2-OE cell line SK-BR-3, the CD44/CD24 ratio was low (Fig. 1C), whereas the expression level of ALDH1 was high (Fig. 1E), suggesting that single CSC marker alone might not be enough to characterize tumor stemness or to evaluate tumor malignancy and prognosis. The gene discussed is CD44; the disease is neoplasm.